Liver X receptors (LXRs) ␣ and ␤ are nuclear oxysterol receptors with a key role in cholesterol, triglyceride, and glucose metabolism. In LXR␤ ؊/؊ mice on a normal diet, there is a reduction in size of perigonadal fat pad and, on high-fat diet there is resistance to obesity. In the present study, we investigated the reason for the resistance of LXR␤ ؊/؊ mice to weight gain. In LXR␤ ؊/؊ mice we found pancreatic exocrine insufficiency with reduced serum levels of amylase and lipase, reduced proteolytic activity in feces, chronic inflammatory infiltration, and, in the ductal epithelium, an increased apoptosis without compensatory proliferation. Electron microscopy revealed ductal dilatation with intraductal laminar structures characteristic of cystic fibrosis. To investigate the relationship between LXR␤ and pancreatic secretion, we studied the expression of LXR␤ and the water channel, aquaporin-1 (AQP1), in the ductal epithelium of the pancreas. In WT mice, ductal epithelial cells expressed LXR␤ in the nuclei and AQP1 on the plasma membrane. In LXR␤ ؊/؊ mice neither LXR␤ nor AQP1 was detectable. Moreover, in WT mice the LXR agonist (T2320) increased AQP1 gene expression. These data demonstrate that in LXR␤ ؊/؊ mice dietary resistance to weight gain is caused by pancreatic insufficiency and that LXR␤ regulates pancreatic exocrine secretion through the control of AQP1 expression. Pancreatic exocrine insufficiency is the main cause of malabsorption syndrome responsible for weight loss in adults and growth failure in children. Several genes are known to be involved in the pathogenesis and susceptibility to pancreatic insufficiency. LXR␤ should be included in that list.
M
alabsorption syndrome is a clinical condition characterized by a combination of symptoms like weight loss or growth failure in children, steatorrhea, diarrhea, and anemia that result from unsuccessful nutrient absorption from the diet. Numerous diseases are responsible for this syndrome, and according to their etiology, they can be classified into three groups: (i) alterations of the digestive process caused by deficit of enzymes and bile acids such as in chronic pancreatitis, cystic fibrosis, and cholestatic liver diseases; (ii) alterations in uptake and transport caused by a damage of absorptive surface such as in celiac disease, CrohnЈs disease, and autoimmune enteropathy; and (iii) microbial causes such as bacterial overgrowth and parasitosis (1) . The major cause of defective intraluminal digestion is pancreatic exocrine insufficiency caused by chronic pancreatitis and cystic fibrosis. In industrialized countries, the incidence of chronic pancreatitis is between 3.5 and 10 per 100,000 inhabitants. About 70-80% of cases are related to long-term alcohol misuse, whereas 10-30% of cases represent idiopathic pancreatitis for which the etiology is still unknown (2) . A large number of mutations in genes coding for serine protease inhibitor, SPINK1, or the cystic fibrosis transmembrane conductance regulator, CFTR, have been described to be involved not only in the pathogenesis of pancreatitis but also, working in concert with other genetic and environmental factors, in the susceptibility to this disease (3) . Moreover, in humans, it has been shown that genetic polymorphisms of genes regulating the inflammatory response, like heat shock protein 70-2 or tumor necrosis factor ␣, are associated with an increased risk of acute pancreatitis (4) .
Liver X receptors, LXR␣ (⌵R1⌯3) and LXR␤ (NR1H2), are nuclear receptors belonging to the superfamily of ligandactivated transcription factors with a key role in controlling lipid and glucose metabolism. Ligands for LXRs are 22-hydroxycholesterol, 24(S)-hydroxycholesterol, 24(S),25-epoxycholesterol, and 27-hydroxycholesterol that at physiological concentrations bind to and activate these receptors (5) . Recently, high concentrations of glucose and D-glucose were reported to be activators of LXRs (6) . Whereas high levels of LXR␣ mRNA are expressed in liver, adipose tissue, adrenal glands, intestine, kidney, macrophages, and lung, LXR␤ mRNA is widely distributed through the body with high levels in the developing brain (7, 8) . LXRs form obligate heterodimers with retinoid X receptor (RXR). The complex LXR/RXR that can be activated by ligands of either partner bind to LXR-responsive elements (LXREs) consisting of a direct repeat (DR4) of the sequence 5Ј-AGGTCA-3Ј separated by 4 nt on the promoter of target genes. LXR target genes are involved in cholesterol transport in liver [ATP-binding cassette transporter (ABC) G5, ABCG8] and macrophages (ABCG1, ABCG4, ABCA1), fatty acid and triglyceride synthesis (fatty acids synthase, acetyl-Coenzyme A carboxylase, stearoylCoenzyme A desaturase 1, sterol regulatory element binding transcription factor), bile acid metabolism (cholesterol 7-␣-hydroxylase), and glucose homeostasis (phosphoenolpyruvate carboxykinase, glucose-6-phosphatase) (9) .
Studies of LXR knockout mice during a fat diet challenge have revealed that the two isoforms, despite their very high sequence homology (78%), have distinct physiological roles in the body. LXR␣ Ϫ/Ϫ mice, fed a diet supplemented with 2% cholesterol, accumulate cholesterol in the liver whereas LXR␤ Ϫ/Ϫ mice are resistant to cholesterol accumulation (10, 11) . In male LXR␤ Ϫ/Ϫ and LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ on a normal diet, the gonadal fat pad is reduced with a decrease in adipocyte size and when fed with a high-fat diet, they are resistant to obesity (12) . Moreover, LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice do not gain weight when fed with a diet containing both high fat and cholesterol (13) .
In the present study we demonstrate that LXR␤ Ϫ/Ϫ mice at 11 months of age on a standard diet exhibit a pancreatic exocrine insufficiency that may be responsible for the described resistance of these mice to gain weight. With specific antibodies we show that both LXR␤ and the water channel aquaporin-1 (AQP1) are expressed in the epithelial cells of the pancreatic ducts in WT mice and that ductal expression of AQP1 is markedly reduced in LXR␤ Ϫ/Ϫ mice. This reduction is likely responsible for the dense secretory fluid in the exocrine pancreas of LXR␤ Ϫ/Ϫ mice visualized by electron microscopy and for the pancreatic insufficiency. In WT mice, 7 days of treatment with an LXR agonist (T2023) significantly increased mRNA levels of AQP1 in WT mice. These findings suggest that LXR␤ plays an important role in controlling pancreatic juice secretion through the regulation of water transport.
Results
Decreased Body Weight and Perigonadal Fat Pad in LXR␤ ؊/؊ Mice. As shown in Table 1 , at 11 months of age, both male and female LXR␤ Ϫ/Ϫ mice had significantly lower body weights, weight/ length ratios, and perigonadal fat pad size than WT mice. Interestingly, the same phenotype was also evident in LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice but not in LXR␣ Ϫ/Ϫ mice, confirming a specific role for LXR␤ in the control of body weight.
In 11-month-old male mice, the caloric intake monitored for 1 week was not different among the four genotypes, whereas a significant increase was detected in LXR␤ Ϫ/Ϫ female mice. Despite the augmented caloric intake, female LXR␤ Ϫ/Ϫ mice showed a reduced weight, similar to male LXR␤ Ϫ/Ϫ mice. Interestingly, even though there was no difference in body weight between LXR␣ Ϫ/Ϫ and WT female mice, the perigonadal fat pad was much smaller in the LXR␣ Ϫ/Ϫ mice, indicating that in these mice there is perhaps fat accumulation in another tissue, probably the liver.
Pancreatic Exocrine Insufficiency in LXR␤ ؊/؊ Mice. Serum levels of lipase and ␣-amylase were significantly decreased in both male and female LXR␤ Ϫ/Ϫ mice, indicating a reduction in secretion of pancreatic enzymes ( Fig. 1 A and B) .
The pancreas secretes a large amount of digestive proteases into the gut. The activity of total proteases in feces was measured by using Azo-casein as a substrate. There was a significant reduction in the proteolytic activity in the feces of both male and female LXR␤ Ϫ/Ϫ mice and in LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ female mice (Fig. 1C ). These data constitute supportive evidence of a pancreatic exocrine insufficiency in LXR␤ Ϫ/Ϫ mice.
Inflammatory Infiltrate with Increased Cell Death in Pancreas of
LXR␤ ؊/؊ Mice. Morphological examination of pancreatic sections stained with hematoxylin-eosin ( Fig. 2 A and B) showed the presence of periductal inflammatory infiltrates around large and medium-sized pancreatic ducts, as described in duct destructive chronic pancreatitis in humans (14) .
Apoptotic cell death was evaluated with TUNEL staining ( Fig.  2 C and D ). An increased number of apoptotic cells was evident in the pancreatic ductal epithelia of LXR␤ Ϫ/Ϫ mice.
Interestingly, there was no significant difference in the number of proliferating ductal cells between WT and LXR␤ Ϫ/Ϫ mice, suggesting that there was no compensatory increase in proliferation to offset the increased apoptosis in LXR␤ Ϫ/Ϫ mice ( Fig. 2 E and F). The same morphology was also evident in male mice (data not shown).
Dilatation of Pancreatic Ducts and Cisternae of Golgi in LXR␤ ؊/؊ Male
Mice. Electron microscopic studies of the pancreas ( Fig. 3 A and B) revealed dilatation of the ducts with dense intraductal material, including laminar structures commonly seen in cystic fibrosis. These findings indicate a highly concentrated pancreatic fluid in LXR␤ Ϫ/Ϫ mice. Cisternae of the Golgi apparatus were enlarged in LXR␤ Ϫ/Ϫ mice ( Fig. 3 C and D) . These ultrastructural alterations of the Golgi are characteristic of when ATP deficiency occurs during pancreatitis (15) .
LXR␤ Is Expressed in the Nuclear Region of Pancreatic Duct Epithelial
Cells. Anti-LXR␤ antibody developed in our laboratory was used to study LXR␤ localization in pancreas with immunohistochemistry and Western blotting. Positive staining was detectable in the nuclei of epithelial cells of pancreatic ducts (Fig. 4A) . Two controls were used to test the specificity of the antibody: first, the positive staining was not evident in pancreas of LXR␤ Ϫ/Ϫ mice (Fig. 4C) ; second, after preadsorption of the antibody with LXR␤ protein the staining in pancreas was negative (Fig. 4B) .
To confirm the presence of LXR␤ in the pancreas, nuclear fractions isolated from WT, LXR␤ Ϫ/Ϫ , and LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice were evaluated by Western blotting (Fig. 4D) . A band of 56 kDa at the same molecular mass as LXR␤ protein standard was detectable in WT extracts but not in LXR␤ Ϫ/Ϫ mouse extracts.
AQP1 mRNA and Protein Levels Are Reduced in LXR␤ ؊/؊ Mice. AQP1 is a water channel expressed in epithelial cells of pancreatic ducts with a key role in transmembrane water movement. To investigate the ethiopathogenesis of the dense secretory fluid in LXR␤ Ϫ/Ϫ mice, AQP1 gene expression was evaluated by realtime RT-PCR and protein localization with immunohistochemistry. In both LXR␤ Ϫ/Ϫ male and female mice, the level of AQP-1 mRNA was lower than in WT littermates (Fig. 5A ). This decrease was much more clearly evident in immunohistochem- istry: in WT mice AQP1 was detectable on the luminal membrane of epithelial cells of pancreatic ducts, whereas in LXR␤ Ϫ/Ϫ female mice AQP1 was almost undetectable in pancreatic ducts but still evident in endothelia of small blood vessels (Fig. 5C ).
The same reduction was found in male mice (data not shown).
The reason for the remaining relatively high levels of AQP-1 mRNA in LXR␤ Ϫ/Ϫ mice is the high levels of expression of this gene in the vascular system (16, 17) . Clearly small blood vessels are abundant in the pancreas and in LXR␤ Ϫ/Ϫ mice they still express high levels of AQP-1. The data suggest that LXR␤ specifically regulates AQP-1 in the ductal epithelium of the pancreas.
AQP1 Expression Is Induced After LXR Agonist Treatment. To evaluate the possibility that AQP-1 could be a target gene of LXR␤, 8-month-old WT male mice were treated with the LXR agonist T2320 for 7 days. AQP-1 expression was studied by RT-PCR (Fig. 6 ). After treatment with T2320, levels of AQP-1 mRNA were significantly higher than those in vehicle-treated mice, indicating that AQP-1 expression is regulated by LXR␤.
Discussion
In this study we show that in male and female LXR␤ Ϫ/Ϫ mice at 11 months of age there is pancreatic exocrine insufficiency that is most likely responsible for the resistance of these mice to weight gain when they are fed a high-fat diet and for their lower body weight on a standard diet (10, 11) . As demonstrated by low pancreatic enzymes in serum, low levels of total protease in the feces (Fig. 1) , massive inflammatory reaction with increased cell death of ductal epithelial cells (Fig. 2) , and obstruction with dense material in the intralobular ducts (Fig. 3) , pancreatic exocrine function in LXR␤ Ϫ/Ϫ mice is severely affected. With a specific antibody directed against LXR␤, we demonstrated the expression of this nuclear receptor in the nuclei of pancreatic ductal epithelial cells (Fig. 4) . Staining was eliminated after preadsorption of the antibody with LXR␤ protein and no staining was detected in pancreatic sections of LXR␤ Ϫ/Ϫ mice. The cause of the dense pancreatic secretion appears to be the loss of the water transporter AQP-1 protein in LXR␤ Ϫ/Ϫ mouse pancreatic ducts (Fig. 5) . The resulting alteration in the composition of pancreatic juice is likely responsible for the apoptotic death of the ductal cells and finally pancreatic insufficiency.
AQP-1 is a membrane water channel protein with a key role in transcellular fluid transport. First identified (17) in erythrocytes and renal proximal tubules, it is also expressed in the digestive system, in particular in endothelial cells of capillaries, small vessels, and lymphatic capillaries of the small intestine (16), in cholangiocytes of liver, bile ducts (18) , and gallbladder (19) , and in the interintra lobular pancreatic ducts (20) where it seems to participate in bile and pancreatic juice formation. Besides an impaired ability to concentrate urine (21, 22) , reduced cerebrospinal fluid production (23), defective angiogenesis and cell migration (24) , and reduced corneal permeability (25) , transgenic mice lacking AQP-1 exhibit one other very interesting metabolic phenotype: on standard chow diet, AQP-1 Ϫ/Ϫ mice show a mild growth retardation (21) and, when fed a high-fat diet, they are resistant to weight gain, develop steatorrhea, and have a decreased concentration of amylase and lipase in pancreatic fluid (26), i.e., a phenotype very similar to that of LXR␤ Ϫ/Ϫ mice (10-12). Interestingly, in AQP-1 Ϫ/Ϫ mice the rate of pancreatic fluid secretion was not affected but composition studies demonstrated lower enzymatic activity of amylase and lipase (26) . It seems that a defective secretion of water in the intrainterlobular pancreatic ducts leads to a modification in the composition of pancreatic secretion.
Recently, an interesting localization of AQP-1 has been demonstrated on the membrane of pancreatic zymogen granules and other secretory vesicles (27) (28) (29) . After stimulation with GTP, AQP-1 rapidly increases the entry of water into the granules, leading to swelling, a key step in exocytosis (28) . Although with immunohistochemistry we did not detect AQP-1 on zymogen granules in our sections, we can suppose that in LXR␤ Ϫ/Ϫ mice an impaired zymogen granule secretion could occur and participate in the pathogenesis of pancreatic exocrine insufficiency.
In this study we also demonstrate that after 7 days of treatment with an LXR agonist (T2320), mRNA levels of AQP-1 are significantly increased in WT mice. Low AQP-1 gene expression in LXR␤ Ϫ/Ϫ mice and the increased expression after LXR agonist treatment support the idea that AQP-1 is regulated by LXR␤ transcriptional activity in the pancreas. Little is known about the transcriptional regulation of the AQP-1 gene. In epithelial cells of the ventricular choroid plexus, the AQP-1 gene is regulated by thyroid transcription factor-1 (TTF-1), (30) , and in efferent ducts of epididymis (31, 32) it is estrogen-regulated. It is not known whether LXR␤ binds directly to the promoter of AQP-1; the AQP-1 5Ј flank has multiple LXRE half sites, and further studies are required to analyze whether any of them is functional. Although immunohistochemical studies in humans have demonstrated the presence of AQP-1 in the intralobular and interlobular pancreatic ducts, nothing is known about the relations between pancreatic exocrine insufficiency, malabsorption, and lack of expression of AQP-1. More studies are required to clarify the regulatory pathway of LXR␤-AQP-1 in human pathophysiology and determine whether LXR␤ can be used as a target in the treatment of diseases associated with a dysregulation of the gastrointestinal fluid balance such as in pancreatic insufficiency and cystic fibrosis.
Materials and Methods
Animals. Mice of WT, LXR␣ Ϫ/Ϫ , LXR␤ Ϫ/Ϫ , and LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ genotypes were generated as described (10) . Mice used in this study were back-crossed to C57BL/6 mice for at least 10 generations and were maintained on a 12-h light/dark cycle under controlled temperature (20 -22°C) and humidity (50 -65%) in the Karolinska University Hospital Animal Facility (Huddinge, Sweden). Animals were given free access to tap water and standard chow diet (RM3; Scanbur Bk) containing 15.15 MJ/kg of gross energy. The quantity of food and the body weight were measured daily for 7 days when mice were 11 months of age. Naso-anal length was determined after death, by pushing the back of the mouse flat with straightened spine by using a digital caliper.
Experiments were approved by the local ethical committee for animal experiments, and the guidelines for the care and use of laboratory animals were followed.
Tissue Processing. Mice were killed by CO 2 asphyxiation, and blood was drawn by intracardiac puncture for subsequent serum collection. Pancreas was removed and fixed overnight in 4% paraformaldehyde at 4°C for immunohistochemical studies or frozen in liquid nitrogen for Western blotting and RT-PCR.
Serum ␣-Amylase and Lipase Assay. Levels of ␣-amylase and lipase in serum were measured with a QuantiChrom Lipase assay kit (DLPS-100; BioAssay Systems) and a QuantiChrom ␣-Amylase assay kit (DAMY-100; BioAssay Systems) according to the manufacturer's instructions.
Measurement of Total Proteases in Mouse Feces.
Fresh feces of WT, LXR␣ Ϫ/Ϫ , LXR␤ Ϫ/Ϫ , and LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice were collected and stored at Ϫ20°C. Samples of 10 mg were suspended in 1 ml of solvent (0.1% Triton X-100, 0.5 M NaCl, and 100 mM CaCl 2), sonicated, and centrifuged at 40,000 ϫ g for 10 min at 4°C as described (33) . The supernatant (0.2 ml) was incubated with 3% Azo-Casein (Fluka 11610) dissolved in 50 mM Tris⅐HCl buffer, pH 8.5 at 37°C for 60 min. After stopping the reaction by the addition of 0.5 ml of 8% trichloroacetic acid, the solution was centrifuged at 9,500 ϫ g for 5 min. The supernatant was subjected to absorbance measurement at 366 nm by using a spectrophotometer (Molecular Devices Spectra Max 250) at room temperature as described (34) . All assays were done in triplicate.
Standard curve was done by using different concentrations of trypsin standard (Promega V511A). Activity was expressed as units/mg feces.
Evaluation of Cell Death and Proliferation.
To identify apoptosis, TUNEL was performed by using an in situ cell death detection kit (Roche) according to the manufacturer's specifications for paraffin-embedded tissues. Pancreatic duct proliferation was evaluated in WT and LXR␤ Ϫ/Ϫ male mice, treated i.p. with BrdU (Roche) dissolved in 0.9% of NaCl at 100 mg/kg every 12 h for 3 days (total of six injections). LXR␤ protein (3 mg/ml) (35) was coupled to Sepharose in 5 ml of sodium bicarbonate for 12 h at 4°C on a wheel. After centrifugation (9,500 ϫ g for 5 min), the pellet was incubated with LXR␤ IgG (1:100 in PBS) for 12 h at 4°C on a wheel. After centrifugation for 5 min at 9,500 ϫ g, the supernatant was used for immunohistochemical staining. As control for preadsorption experiments, BSA was coupled to activated Sepharose.
Generation of Antibody
Immunohistochemistry. Representative blocks of paraffin-embedded tissues were cut at 4-m thickness, dewaxed in xylene, and rehydrated through graded ethanol. Antigens were retrieved by boiling 10 mM citrate buffer (pH 6.0) for 5 min. Cooled sections were incubated in 3% H2O2 in 50% methanol for 30 min at room temperature to quench endogenous peroxidase, and then incubated in 0.5% Triton X-100 in PBS for 10 min. For BrdU staining, before Triton X-100 incubation, sections were incubated in 2 M hydrochloric acid for 10 min, followed by incubation for 15 min at room temperature in a solution of 0.05 M NaCl and 0.05 M sodium tetraborate (pH 8.5) in 0.2 M boric acid. To block nonspecific binding, sections were incubated in PBS containing 1% BSA and 0.1% Nonidet P-40 for 1 h at 4°C. Sections were incubated with the following antibodies: anti-LXR␤ (1:100), anti-BrdU (1:100; Biosciences Pharmingen), anti-AQP1 (1:100; Alpha Diagnostic International) in PBS containing 1% BSA and 0.1% Nonidet P-40 overnight at 4°C. Negative controls were incubated with PBS containing 1% BSA and 0.1% Nonidet P-40 without primary antibody. After washing, sections were incubated with the corresponding secondary antibodies (1:200; Zymed Laboratories), rabbit anti-goat IgG for LXR␤ staining, goat anti-mouse IgG for BrdU staining, and goat anti-rabbit for AQP1 staining at room temperature for 1 h. The Vectastain ABC kit (Vector Laboratories) was used for the avidin-biotin complex method to visualize the signal, following the manufacturer's instructions. After washing in PBS, sections were developed with 3,3Ј-diaminobenzidine tetrahydrochloride substrate (DAKO). A light counterstaining with MayerЈs hematoxylin was done. Sections were dehydrated through a graded ethanol series and xylene and then mounted.
Western Blotting. Pancreatic nuclear fractions from WT, LXR␤ Ϫ/Ϫ , and LXR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice were analyzed by Western blotting. Frozen pancreatic tissues were homogenized for 1 min each with a Polytron in 25 ml of PBS containing protease inhibitor mixture according to the supplier's instructions (Roche Diagnostics). The protein content was measured by Bio-Rad protein assay with BSA as standard. Twenty micrograms of protein was dissolved in SDS sample buffer and resolved on 4 -20% gradient SDS/polyacrylamide gels (Invitrogen) in Tris-glycine buffer. Proteins were transferred to PVDF membranes (Amersham Pharmacia Biosciences) by electroblotting in Tris⅐glycine buffer. Molecular weight markers were PageRuler Prestained Protein Ladder Plus (Fermentas). The membrane was then incubated in blocking solution containing 3% BSA and 0.1% Nonidet P-40 in PBS for 1 h at room temperature. Incubation with goat anti-LXR␤ (1:5,000) was performed in blocking solution overnight at 4°C. For positive control, LXR␤ protein was used (35) . After washing, secondary peroxidase-conjugated donkey anti-goat antibody (1:10,000; Santa Cruz Biotechnology) was applied in blocking solution for 1 h at room temperature. After washing, detection with an enhanced chemiluminescence kit (Amersham Pharmacia) was performed.
Transmission Electron Microscopy. Pancreas was dissected, and small pieces were immediately fixed in 2% glutaraldehyde ϩ 0.5% paraformaldehyde in 0.1 M sodium cacodylate buffer containing 0.1 M sucrose and 3 mM CaCl2, pH 7.4, at room temperature and stored at 4°C until further processing. Specimens were rinsed in 0.15 M sodium cacodylate buffer containing 3 mM CaCl2, pH 7.4, postfixed in 2% osmium tetroxide in 0.07 M sodium cacodylate buffer containing 1.5 mM CaCl2, pH 7.4 at 4°C for 2 h, dehydrated in ethanol followed by acetone, and embedded in LX-112 (Ladd). Semithin sections were cut and stained with toluidine blue and used for light microscopic analysis. Ultrathin sections (Ϸ40 -50 nm) were cut and contrasted with uranyl acetate followed by lead citrate and examined in a Leo 906 transmission electron microscope at 80 kV. Digital images were taken with a Morada digital camera (Soft Imaging System) (36) .
LXR Agonist Treatment.
Five male C57B16/J mice, 8 months of age, were treated with 20 mg/kg body weight of LXR agonist T0901317 (T2320 SigmaAldrich), dissolved in DMSO/PBS (1:3), given daily by oral gavage for 7 days. Six mice were given only vehicle for 7 days.
